Загрузка...
Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy
Abnormal metabolism is another cancer hallmark. The two most characterized altered metabolic pathways are high rates of glycolysis and glutaminolysis, which are natural targets for cancer therapy. Currently, a number of newer compounds to block glycolysis and glutaminolysis are being developed; neve...
Сохранить в:
| Опубликовано в: : | Biomed Res Int |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi Publishing Corporation
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4575731/ https://ncbi.nlm.nih.gov/pubmed/26425550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/690492 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|